SCHEMBL8348169

SCHEMBL8348169

CC(/C=C\S)=C(/C)CC(C)C

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL790457 0.64
SCHEMBL4348939 0.64 ALDH1A1 (0.47) ALDH1A1TDP1
SCHEMBL4348941 0.64 ALDH1A1 (0.47) ALDH1A1TDP1
SCHEMBL16384397 0.62 ALDH1A1 (0.35) ALDH1A1TDP1
SCHEMBL22752078 0.60 ALDH1A1 (0.33) ALDH1A1TDP1
SCHEMBL15871787 0.60 ALDH1A1 (0.33) ALDH1A1TDP1
SCHEMBL23097205 0.60
SCHEMBL18953059 0.60 ALDH1A1 (0.43) ALDH1A1TDP1
SCHEMBL18953058 0.60 ALDH1A1 (0.43) ALDH1A1TDP1
SCHEMBL2622446 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003030886-A2 ALLYLAMIDES USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC (US) 2003-04-17 WO disclosed